_parpi-olaparib-for-the-targeted-treatment-of-metastatic-prostate-cancer-preview-1.jpg "PARPi olaparib for the targeted treatment of metastatic prostate cancer from olaparib prostate cancer Video Screenshot Preview 1")
Gallery_parpi-olaparib-for-the-targeted-treatment-of-metastatic-prostate-cancer-preview-3.jpg "PARPi olaparib for the targeted treatment of metastatic prostate cancer from olaparib prostate cancer Video Screenshot Preview 3")
Gallery_parpi-olaparib-for-the-targeted-treatment-of-metastatic-prostate-cancer-preview-hqdefault.jpg "PARPi olaparib for the targeted treatment of metastatic prostate cancer from olaparib prostate cancer Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 49 seconds
👁 View: 213 times
Play Audio:👁 View: 213 times
Description:
Vall d'Hebron Institute of Oncology - VHIO
Vall d'Hebron Institute of Oncology - VHIO
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_the-benefits-of-177lu-psma-617-plus-olaparib-for-prostate-cancer.webp "VJOncology")
_the-propel-clinical-trial-exploring-olaparib-plus-abiraterone-in-mcrpc.webp "VJOncology")
_parp-inhibitors-for-metastatic-hormone-sensitive-prostate-cancer.webp "VJOncology")
_parpi-olaparib-for-the-targeted-treatment-of-metastatic-prostate-cancer.webp "Vall d'Hebron Institute of Oncology - VHIO")
_olaparib-plus-abiraterone-for-mcrpc-are-biomarkers-necessary.webp "VJOncology")
_olaparib-plus-abiraterone-could-be-a-new-first-line-treatment-option-for-mcrpc-124-fred-saad.webp "Medicine Matters oncology")
⏲ 3 minutes 41 seconds 👁 193
_niraparib-and-abiraterone-acetate-for-metastatic-castration-resistant-prostate-cancer.webp "ASCOcancer")
⏲ 2 minutes 59 seconds 👁 1.4K
_exciting-times-for-hormone-sensitive-prostate-cancer-treatment.webp "VJOncology")
_the-benefits-of-177lu-psma-617-plus-olaparib-for-prostate-cancer.jpg)
_the-propel-clinical-trial-exploring-olaparib-plus-abiraterone-in-mcrpc.jpg)
_parp-inhibitors-for-metastatic-hormone-sensitive-prostate-cancer.jpg)
_parpi-olaparib-for-the-targeted-treatment-of-metastatic-prostate-cancer.jpg)
_olaparib-plus-abiraterone-for-mcrpc-are-biomarkers-necessary.jpg)
_olaparib-plus-abiraterone-could-be-a-new-first-line-treatment-option-for-mcrpc-124-fred-saad.jpg)
_niraparib-and-abiraterone-acetate-for-metastatic-castration-resistant-prostate-cancer.jpg)
_exciting-times-for-hormone-sensitive-prostate-cancer-treatment.jpg)
![[+]](/images/menu.gif){kind=small}